BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,540 | +0.4% | 3,137 | +26.3% | 0.00% | – |
| Q2 2023 | $156,988 | +28.7% | 2,484 | -8.4% | 0.00% | – |
| Q1 2023 | $121,967 | +4.7% | 2,711 | +1.9% | 0.00% | – |
| Q4 2022 | $116,534 | -34.9% | 2,660 | -2.2% | 0.00% | – |
| Q3 2022 | $179,000 | +55.7% | 2,719 | +19.0% | 0.00% | – |
| Q2 2022 | $115,000 | -92.9% | 2,285 | -91.0% | 0.00% | -100.0% |
| Q1 2022 | $1,628,000 | -52.6% | 25,495 | -20.5% | 0.00% | -50.0% |
| Q4 2021 | $3,435,000 | – | 32,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |